Animal studies suggest new paths to treating depression

Nov 16, 2010

New animal research has identified factors, such as the stress response and immune system, that may play important roles in depression. Scientists have also found that the regulation of nerve cell signals influences depression in animals, and that new drug combinations may more effectively treat it. The findings were presented at Neuroscience 2010, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health.

Depression is a common mental disorder that affects more than 121 million people worldwide, according to the World Health Organization. Studies show the most effective treatment for moderate or is a combination of antidepressant medication and psychotherapy. However, 20 to 40 percent of people with are not helped by existing therapies, highlighting the need for new treatment targets and approaches.

Today's new findings show that:

  • An inability to cope with stress may play a role in depression. When placed in stressful situations, zebrafish with a mutation in a receptor important in stress management displayed depression-like behavior, which was reversed when the fish were given Prozac (Herwig Baier, PhD, abstract 884.1, see attached summary).
  • The immune system may be a factor in depression. When an immune hormone that carries "sickness" signals to the brain was blocked in mice, the animals showed fewer depression symptoms (Simon Sydserff, PhD, abstract 666.24, see attached summary).
  • Mice that lack a molecule involved in regulating nerve cell signals are more active and resilient to , behaving the same way as animals given antidepressant drugs. The discovery offers a new target for controlling involved in mood regulation (James Bibb, PhD, abstract 741.9, see attached summary).
  • Two antidepressants may be better than one. A new animal study shows that when drugs that alter two mood-regulating brain chemicals are combined, they produce a greater antidepressant response (Marina Picciotto, PhD, abstract 769.9, see attached summary).
Other recent findings discussed show that:
  • Two brain molecules, p11 and brain-derived neurotrophic factor, are key to making antidepressants work. In time, these results might lead to the development of faster-acting antidepressants with fewer side effects (Jennifer Warner-Schmidt, PhD, see attached speaker's summary).
"Finding treatments for disorders of the nervous system is a social imperative," said press conference moderator Robert Greene, MD, PhD, of the University of Texas Southwestern Medical School, an expert in psychiatric disorders. "Basic neuroscience research has formed the basis for significant progress in discovering potentially powerful strategies for new, more effective therapies to combat depression."

Explore further: Growing a blood vessel in a week

More information: www.sfn.org/am2010/press/OmniP… s/data/press/004.pdf

add to favorites email to friend print save as pdf

Related Stories

Studies expand oxytocin's role beyond 'cuddle hormone'

Nov 15, 2010

New human research suggests the chemical oxytocin — dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children — also influences feelings of well-being and ...

Brain protein may be a target for fast-acting antidepressants

Feb 25, 2009

(PhysOrg.com) -- It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11, previously ...

Study suggests new target for treatment of depression

Apr 28, 2009

A brain protein involved in fear behavior and anxiety may represent a new target for depression therapies, according to a study by researchers at the University of Iowa and the Iowa City Veterans Affairs Medical Center. The ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0